Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Paleacu

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Neuropsychiatric Disease and Treatment|April 22, 2009
Tetrabenazine in the treatment of Huntington's diseaseDiana Paleacu
Asian Journal of Psychiatry|July 4, 2018
Isolated vocal akathisia-Does it exist?Diana Paleacu Kertesz, Doron Maze
The Israel Journal of Psychiatry and Related Sciences|September 5, 2009
Narcolepsy and psychotic states--a case reportYuval Melamed, Yael Daliahu, Diana Paleacu
Archives of Gerontology and Geriatrics|August 4, 2010
Quetiapine augmentation of antidepressant treatment in elderly patients suffering from depressive symptoms: a retrospective chart reviewShelly Tadger, Diana Paleacu, Yoram Barak
Neurology|May 25, 2005
Association between family history of dementia and hallucinations in Parkinson diseaseDiana Paleacu, Edna Schechtman, Rivka Inzelberg
Psychiatry Research|October 12, 2007
Quetiapine for elderly non-responsive schizophrenia patientsDoron Mazeh, Diana Paleacu, Yoram Barak
The Journal of ECT|September 3, 2014
Headache treatment after electroconvulsive treatment: a single-blinded trial comparator between eletriptan and paracetamolDiana Paleacu Kertesz, Olga Trabekin, Marnina Swartz Vanetik
International Psychogeriatrics|April 16, 2011
Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: a randomized double-blind pilot studyYoram Barak, Igor Plopski, Shelly Tadger, et al.
The Journal of ECT|July 14, 2020
A Pilot Study of Cognitive Impairment in Longstanding Electroconvulsive Therapy-treated Schizophrenia Patients Versus ControlsRenana Danenberg, Liad Ruimi, Assaf Shelef, et al.
Clinical Neuropharmacology|December 7, 2002
Donepezil for the treatment of behavioral symptoms in patients with Alzheimer's diseaseDiana Paleacu, Doron Mazeh, Ilona Mirecki, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Neuropsychiatric Disease and Treatment|April 22, 2009
Tetrabenazine in the treatment of Huntington's diseaseDiana Paleacu
Asian Journal of Psychiatry|July 4, 2018
Isolated vocal akathisia-Does it exist?Diana Paleacu Kertesz, Doron Maze
The Israel Journal of Psychiatry and Related Sciences|September 5, 2009
Narcolepsy and psychotic states--a case reportYuval Melamed, Yael Daliahu, Diana Paleacu
Archives of Gerontology and Geriatrics|August 4, 2010
Quetiapine augmentation of antidepressant treatment in elderly patients suffering from depressive symptoms: a retrospective chart reviewShelly Tadger, Diana Paleacu, Yoram Barak
Neurology|May 25, 2005
Association between family history of dementia and hallucinations in Parkinson diseaseDiana Paleacu, Edna Schechtman, Rivka Inzelberg
Psychiatry Research|October 12, 2007
Quetiapine for elderly non-responsive schizophrenia patientsDoron Mazeh, Diana Paleacu, Yoram Barak
The Journal of ECT|September 3, 2014
Headache treatment after electroconvulsive treatment: a single-blinded trial comparator between eletriptan and paracetamolDiana Paleacu Kertesz, Olga Trabekin, Marnina Swartz Vanetik
International Psychogeriatrics|April 16, 2011
Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: a randomized double-blind pilot studyYoram Barak, Igor Plopski, Shelly Tadger, et al.
The Journal of ECT|July 14, 2020
A Pilot Study of Cognitive Impairment in Longstanding Electroconvulsive Therapy-treated Schizophrenia Patients Versus ControlsRenana Danenberg, Liad Ruimi, Assaf Shelef, et al.
Clinical Neuropharmacology|December 7, 2002
Donepezil for the treatment of behavioral symptoms in patients with Alzheimer's diseaseDiana Paleacu, Doron Mazeh, Ilona Mirecki, et al.
Pageof 2